Not Medicare Enrolled
Dr. David Phillips, MD
Urology Physician · Austin, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Phillips from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Phillips?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Phillips
Dr. David Phillips is an urology physician in Austin, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Phillips performed 17,718 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Phillips received a total of $12,935 from 61 pharmaceutical and/or device companies across 589 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Phillips is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 4% volume in TX
$12,935 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗17,718
Medicare services
Top 4% in TX for urology physician
Not available
Unique patients (not deduplicated)
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 12,000 | $19 | $43 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
1,100 | $0 | $1 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
911 | $47 | $77 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
858 | $93 | $249 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
644 | $2 | $7 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
412 | $8 | $15 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
359 | $38 | $77 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
335 | $60 | $168 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 264 | $135 | $2,000 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
189 | $47 | $82 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
144 | $8 | $44 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
78 | $58 | $175 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
74 | $116 | $380 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
61 | $28 | $76 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
58 | $160 | $477 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
48 | $61 | $167 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
44 | $0 | $3 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
30 | $118 | $336 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
24 | $100 | $316 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
21 | $82 | $250 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
17 | $153 | $508 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
17 | $111 | $250 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
17 | $10 | $59 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
13 | $3 | $10 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$12,935
Total received (2018-2024)
Avg $1,848/year across 7 years
Top 16% in TX for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
589
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,378
2023
$1,786
2022
$1,733
2021
$1,496
2020
$2,856
2019
$1,616
2018
$2,069
Payments by company (2024)
ABBVIE INC.
$311
Janssen Biotech, Inc.
$308
PFIZER INC.
$149
Sumitomo Pharma America, Inc.
$138
Olympus America Inc.
$136
Merck Sharp & Dohme LLC
$76
Astellas Pharma US Inc
$69
Ferring Pharmaceuticals Inc.
$43
Dendreon Pharmaceuticals LLC
$34
Boston Scientific Corporation
$33
Medtronic, Inc.
$29
Bayer Healthcare Pharmaceuticals Inc.
$24
Endo USA, Inc.
$15
Tempus AI, Inc
$14
Top 3 companies account for 55.7% of 2024 payments
All-time payments by company (2018-2024) ›
Dendreon Pharmaceuticals LLC
$2,337
Janssen Biotech, Inc.
$1,703
PFIZER INC.
$1,637
Astellas Pharma US Inc
$1,040
ABBVIE INC.
$799
Blue Earth Diagnostics Limited
$522
Bayer HealthCare Pharmaceuticals Inc.
$390
Boston Scientific Corporation
$370
Endo Pharmaceuticals Inc.
$285
Amgen Inc.
$280
AbbVie, Inc.
$261
Sumitomo Pharma America, Inc.
$202
Olympus America Inc.
$182
BOSTON SCIENTIFIC CORPORATION
$177
AbbVie Inc.
$157
Janssen Scientific Affairs, LLC
$150
Foundation Medicine, Inc.
$150
Merck Sharp & Dohme LLC
$140
Myovant Sciences Inc.
$130
Allergan Inc.
$120
Allergan, Inc.
$116
Progenics Pharmaceuticals, Inc.
$110
Antares Pharma, Inc.
$98
Aytu BioScience, Inc
$97
Bayer Healthcare Pharmaceuticals Inc.
$87
Sun Pharmaceutical Industries Inc.
$86
Janssen Products, LP
$85
PROCEPT BioRobotics Corporation
$84
AstraZeneca Pharmaceuticals LP
$81
Ferring Pharmaceuticals Inc.
$74
TOLMAR Pharmaceuticals, Inc.
$71
Rochester Medical Corporation
$62
Clarus Therapeutics Inc.
$60
Merck Sharp & Dohme Corporation
$60
Travere Therapeutics, Inc.
$56
Myriad Genetic Laboratories, Inc.
$55
Avadel Specialty Pharmaceuticals, LLC
$51
Accord Healthcare, Inc.
$47
Axonics, Inc.
$47
UROGEN PHARMA, INC.
$46
KARL STORZ Endoscopy-America
$45
Mission Pharmacal Company
$33
180 Medical, Inc.
$30
Kowa Pharmaceuticals America, Inc.
$30
Medtronic, Inc.
$29
Tolmar, Inc.
$29
Janssen Pharmaceuticals, Inc
$27
ConvaTec Inc.
$19
GENZYME CORPORATION
$16
TherapeuticsMD, Inc.
$16
DENTSPLY IH Inc.
$15
Abbott Laboratories
$15
Acerus Pharmaceuticals Corporation
$15
Clovis Oncology, Inc.
$15
Endo USA, Inc.
$15
Ambu Inc.
$14
UroGen Pharma, Inc.
$14
Metuchen Pharmaceuticals
$14
Tempus AI, Inc
$14
Integra LifeSciences Corporation
$13
NeoTract Inc.
$13
Top 3 companies account for 43.9% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · 16 FR. FLEXIBLE VIDEO CYSTOSCOPE · ADSTILADRIN · AMS · AMS 700 · AMS 700 CXR RTE KIT · AQUABEAM ROBOTIC SYSTEM · AVEED · AVYCAZ · Androgel · AquaBeam Robotic System · Axonics · Axumin · BIOFIX · BOTOX · BOTOX THERAPEUTIC · BRACANALYSIS CDX · CAMCEVI · EDEX · ELIGARD · ERLEADA · Erleada · FOUNDATIONONE · FOUNDATIONONE CDX · GEMTESA · GENERAL MALE SUI · GENERAL BPH · GENTLECATH · General - Male SUI · IMVEXXY · INTELLIS ADAPTIVESTIM · JATENZO · JELMYTO · JEVTANA · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LoFric · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · Otrexup · PROCLAIM · PROVENGE · PYLARIFY · Prolaris · Prolia · Rubraca · SEGLENTIS · SUTENT · Seglentis · Stendra · TACTRA · TOVIAZ · Thiola · UroLift · Urocit-K · VIAGRA · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · ZYTIGA · iTIND System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
63
County median income
$97,169
Nearest hospital to ZIP centroid (approximate)
AUSTIN OAKS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | — Not enrolled | N/A |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Phillips is a clinical cardiology specialist, with above-average Medicare volume (top 4% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Phillips experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Phillips performed 12,000 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Phillips receive payments from pharmaceutical companies?
Yes. Dr. Phillips received a total of $12,935 from 61 companies across 589 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Phillips's costs compare to other urology physicians in Austin?
Dr. Phillips's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Phillips) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Austin
Browse urology physicians in Austin ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology